Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Canadian Sec - Delayed Quote CAD

Lophos Holdings Inc. (MESC.CN)

0.0100
0.0000
(0.00%)
At close: September 4 at 9:32:36 AM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
Operating Expense
997.7010
997.7010
816.7240
Operating Income
-997.7010
-997.7010
-816.7240
Net Non Operating Interest Income Expense
-196.2710
-196.2710
-170.9910
Other Income Expense
-80.3070
-80.3070
--
Pretax Income
-1,274.2790
-1,274.2790
-987.7150
Tax Provision
2.4030
2.4030
--
Net Income Common Stockholders
-1,276.6820
-1,276.6820
-987.7150
Diluted NI Available to Com Stockholders
-1,276.6820
-1,276.6820
-987.7150
Basic EPS
-0.02
--
-0.01
Diluted EPS
-0.02
--
-0.01
Basic Average Shares
84,023.7120
--
85,859.6730
Diluted Average Shares
84,023.7120
--
85,859.6730
Total Expenses
997.7010
997.7010
816.7240
Net Income from Continuing & Discontinued Operation
-1,276.6820
-1,276.6820
-987.7150
Normalized Income
-1,208.4211
-1,208.4211
-987.7150
Interest Expense
196.2710
196.2710
170.9910
Net Interest Income
-196.2710
-196.2710
-170.9910
EBIT
-1,078.0080
-1,078.0080
-816.7240
EBITDA
-1,049.7920
-1,049.7920
-776.6100
Reconciled Depreciation
28.2160
28.2160
40.1140
Net Income from Continuing Operation Net Minority Interest
-1,276.6820
-1,276.6820
-987.7150
Total Unusual Items Excluding Goodwill
-80.3070
-80.3070
--
Total Unusual Items
-80.3070
-80.3070
--
Normalized EBITDA
-969.4850
-969.4850
-776.6100
Tax Rate for Calcs
0.0002
0.0002
--
Tax Effect of Unusual Items
-12.0461
-12.0461
--
3/31/2023 - 9/6/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MSCL.TO Satellos Bioscience Inc.
0.6600
+6.45%
 
PHRM.CN PharmaTher Holdings Ltd.
0.1850
0.00%
 
PHRRF PharmaTher Holdings Ltd.
0.1390
+6.92%
 
MDMA.CN Pharmala Biotech Holdings Inc.
0.1400
0.00%
 
PPBT Purple Biotech Ltd
2.7300
+1.11%
 
PRTA Prothena Corporation plc
9.65
+0.63%
 
CYBN Cybin Inc.
7.06
+2.02%
 
ALLR Allarity Therapeutics, Inc.
1.0700
+5.94%